Inhibrx Biosciences Inc(INBX)
$74.33+5.27 (+7.63%)
INBX
Inhibrx Biosciences Inc earnings date
$74.33
At close:+5.27 (+7.63%)
Want to see INBX full AI Analyst Report?
Inhibrx Biosciences Inc (INBX) Q2 2026 Earnings Report
123 Followers
INBX Q2 2026 EPS Results
- Actual EPS
- -$2.34
- Consensus EPS
- -$2.28
- Beat/Miss
- Missed by -$0.06
- One Year Ago EPS
- -$1.85
INBX Q2 2026 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- -100.00%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/13/2026
- Time
- After Close
- Conference Call
- Thursday, August 13, 2026
INBX Upcoming Earnings
Inhibrx Biosciences Inc's next earnings date is estimated for March 24, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
INBX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 24, 2027 | 2026 (Q4) | -2.55- | -2.11 | ― | ― |
| Nov 13, 2026 | 2026 (Q3) | -2.45-2.46 | -2.28 | -7.89% (-0.18) | |
| Aug 13, 2026 | 2026 (Q2) | -2.28-2.34 | -1.85 | -26.49% (-0.49) | |
| May 14, 2026 | 2026 (Q1) | -1.68-2.15 | -2.8 | 23.21% (+0.65) | |
| Mar 19, 2026 | 2025 (Q4) | -2.08-2.11 | -3.09 | 31.72% (+0.98) | |
| Nov 14, 2025 | 2025 (Q3) | -1.72-2.28 | -2.84 | 19.72% (+0.56) | |
| Aug 13, 2025 | 2025 (Q2) | -2.76-1.85 | 125.48 | -101.47% (-127.33) | |
| May 14, 2025 | 2025 (Q1) | -2.83-2.80 | -1.44 | -94.44% (-1.36) | |
| Mar 17, 2025 | 2024 (Q4) | -2.88-3.09 | ― | ― | |
| Nov 14, 2024 | 2024 (Q3) | -3.38-2.84 | ― | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

